Zimmer Biomet Holdings, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NYSE
Zimmer Biomet Holdings, Inc. filed its definitive proxy statement for the 2026 annual meeting, outlining strong 2025 financial performance, executive compensation, and board recommendations on key governance matters.
NYSE
Zimmer Biomet Holdings, Inc. announces its 2024 Annual Meeting of Stockholders to be held on May 10, 2024, outlining key voting items and access to proxy materials.
NYSE
Zimmer Biomet releases its proxy statement, outlining key proposals for the upcoming 2025 annual meeting, including director elections, auditor ratification, and executive compensation.
NYSE
Zimmer Biomet Holdings, Inc. announces its 2024 Annual Meeting of Stockholders to be held on May 10, 2024, outlining key voting items including the election of directors, ratification of the independent auditor, executive compensation, and approval of the amended Employee Stock Purchase Plan.
NYSE
DEF 14A: Zimmer Biomet Holdings, Inc. Outlines Key Governance and Compensation Strategies in Proxy Statement
Zimmer Biomet's proxy statement details the company's corporate governance framework, executive compensation practices, and proposals for the upcoming annual shareholder meeting.